Why Attend the DNA Process Development & Manufacturing Summit?
The 3rd DNA Process Development & Manufacturing Summit is the only industry-focused event dedicated exclusively to advancing DNA technologies from plasmid and synthetic DNA production through scalable, regulatory-compliant manufacturing.
Driven by rapid growth in cell and gene therapies, mRNA vaccines, and precision diagnostics, DNA is at the heart of next-generation therapeutics. Innovations in process design, purification, and analytical testing are enabling higher yields, improved quality, and faster timelines, transforming DNA into a cornerstone of modern biologics.
Join 110+ leaders from Pfizer, Sanofi, Moderna, Beam Therapeutics, GSK, and more to explore how cutting-edge manufacturing approaches, process optimization strategies, and regulatory insights are empowering scalable, high-quality DNA production.
As the global demand for DNA continues to surge, this summit offers a unique opportunity to stay ahead of the curve, connect with experts shaping the field, and gain the practical insights needed to advance your DNA programs from development to commercial-scale manufacturing.
What to Expect?
Identify analytical strategies and sequencing methods essential for ensuring DNA fidelity and quality by establishing critical quality attributes, closing gaps in accuracy assessment, and advancing industry-wide standards, with insights from
Expand manufacturing capacity by scaling DNA production for clinical and commercial programs, guided by CMC regulatory expectations and supply-chain planning, with expertise from Beam Therapeutics and
Advance upstream and downstream DNA process development through innovative plasmid design and improved fermentation, lysis, chromatography, and purification methods to accelerate release timelines, featuring strategies from HDT
Evaluate synthetic DNA platforms and assess their advantages and challenges, including timelines, cost efficiency, quality, and immunogenicity, to guide future manufacturing decisions, with insight from Pfizer and
Forge collaborative partnerships with biopharma leaders and technology innovators to shape the future of DNA production, leveraging advanced tools and platforms to streamline manufacturing alongside Touchlight, Xpress Biologics, and
What's New for 2026?
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque facilisis leo risus, sed molestie eros cursus id. Integer hendrerit tincidunt bibendum. Mauris molestie ex sed ante egestas, ac tincidunt diam dapibus.
17 new speakers
From leading organizations including Sanofi, GSK, Pfizer, Boehringer Ingelheim, and more
2 workshops
Exploring optimizing plasmid DNA production workflows and strategies for building quality excellence across nucleic acid–based therapeutics
Unpublished insights
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque facilisis leo risus, sed molestie eros cursus id
Attending Companies Include